Agilent Technologies, Inc. (A) - Medical Equipment - Deals and Alliances Profile

Date: October 18, 2016
Pages: 137
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AD7A301FDA8EN
Leaflet:

Download PDF Leaflet

Agilent Technologies, Inc. (A) - Medical Equipment - Deals and Alliances Profile
Summary

Agilent Technologies, Inc. (Agilent) is a provider of instruments, reagents, software, services and consumables to diagnostics, life sciences and applied chemical markets for comprehensive laboratory workflow. The company offers its products to biotechnology, pharmaceutical, CRO and CMO, chemical and energy, environmental and forensics, and food industries. Agilent markets its products through direct sales force, distributors, manufacturers’ representatives, resellers and e-commerce. The company conducts research and development (R&D) activities through Agilent Technologies Research Laboratories. Agilent has R&D and manufacturing facilities in California, Colorado, Delaware and Texas in the US; Denmark, Germany, Italy, Japan, Malaysia, China, Singapore and Australia. Agilent is headquartered in Santa Clara, California, the US.

Agilent Technologies, Inc. (A) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Agilent Technologies, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Agilent Technologies, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Agilent Technologies, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Agilent Technologies, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Agilent Technologies, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Agilent Technologies, Inc., Medical Equipment, Deal Details
Asset Purchase
Dako To Acquire Intellectual Property Rights From System Dynamics
Venture Financing
Seahorse Bioscience Raises US$11 Million In Series E Financing
Seahorse Bioscience Secures US$5 Million In Series D Financing
Private Equity
Linden Acquires Hycor Biomedical From Agilent Technologies
Partnerships
Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection
Seahorse Bioscience Enters Into Licensing Agreement With Pioneer Valley Life Sciences
Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool
Agilent Technologies Enters Into Licensing Agreement With Kreatech Diagnostics
Agilent Technologies Enters into Agreement with Burning Rock Biotech
Agilent Technologies Enters into Co-Marketing Agreement with Applied Spectral Imaging
Agilent Technologies Enters into Agreement with Eurofins Genomics
Agilent Technologies Enters into Agreement with 10X Genomics
Agilent Technologies Enters into Agreement with Thermo Fisher Scientific
Merck and Pfizer Enters into Agreement with Dako
Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic
Dako Enters into Development Agreement with ONO PHARMA for Opdivo
Agilent Extends Co-Marketing Agreement with MRM Proteomics
Dako Enters into Agreement with Merck for Companion Diagnostic Test
Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine
Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test
Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay
Agilent Enters Into Research Agreement With Chungnam National University
Agilent Technologies Enters Into Co-Development Agreement With Florida International University
Agilent Technologies Enters Into Co-Development Agreement With Sera Prognostics
Dako Enters Into Agreement With Pfizer For Companion Diagnostics
Agilent Technologies Enters Into Research Agreement With Ameritox
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests
Advion Enters Into Technology Integration Agreement With Agilent Technologies
Agilent Technologies Enters Into Co-Marketing Agreement With Molecular Discovery
Agilent Technologies Enters Into Co-Marketing Agreement With MRM Proteomics
Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers
Dako Enters Into Co-Development Agreement With Amgen
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics
Dako Enters Into Co-Development Agreement With Amgen
Dako Enters Into Co-Development Agreement With Bristol-Myers
Agilent Technologies Enters Into Co-Marketing Agreement With Bridge12 Technologies
Dako Denmark Enters Into Co-Development Agreement With Epitomics
Nikon Instruments Enters Into Distribution Agreement With Agilent Technologies
Dako Enters Into Distribution Agreement With BioPorto
Agilent Technologies Enters Into Collaboration With Wyss Institute for Biologically Inspired Engineering at Harvard University
Dako Enters Into Agreement With Quintiles Transnational
Royal Philips Electronics Signs An Agreement With Dako
Dako Enters Into An Agreement With Omnyx
Agilent Technologies Enters Into Co-Marketing Agreement With Integrated DNA Technologies
BIOCIUS Life Sciences Enters Into Distribution Agreement With Wako Pure Chemical Industries
AstraZeneca Enters Into Co-Development Agreement With Dako Denmark
Agilent Technologies Enters Into Co-Marketing Agreement Covaris
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology
Eppendorf Enters Into Licensing Agreement With Agilent Technologies
Debt Offering
Agilent Technologies Raises USD300 Million in Public Offering of Notes Due 2026
Agilent Technologies Completes Public Offering Of Notes Due 2023 For US$600 Million
Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million
Agilent Technologies Completes Public Offering Of 2.5% Senior Notes For US$250 Million
Agilent Technologies Completes Public Offering Of 5% Senior Notes For US$500 Million
Asset Transactions
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies
Persistent Systems Completes Acquisition Of Software Business From Agilent Technologies
Bruker Completes Acquisition Of Three Varian Product Lines From Agilent Technologies
Acquisition
Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million
Agilent Technologies Acquires Seahorse Bioscience for USD235 Million
Agilent to Acquire Cartagenia
Agilent Technologies To Acquire ABC Instrumentacion Analitica
Leica Biosystems Completes Acquisition Of Aperio Technologies
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion
Agilent Technologies Completes Acquisition Of BioSystem Development
Agilent Technologies Acquires P.V.R.
Agilent Technologies Acquires Lab901
Agilent Technologies Completes Acquisition Of Varian
Agilent Technologies, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Dec 08, 2015: Protea Announces Biopharm Industry Collaboration
Sep 23, 2015: Agilent Technologies Announces Opening of Life Science Research Center at Carleton University
May 19, 2015: Agilent Technologies Advances Solutions to Drive Better Outcomes for Customers
Financial Announcements
Aug 17, 2016: Agilent Technologies Reports Third-Quarter 2016 Results
May 16, 2016: Agilent Technologies Reports Second-Quarter 2016 Results
Feb 16, 2016: Agilent Technologies Reports First-Quarter 2016 Results
Nov 16, 2015: Agilent Technologies Reports Fourth-Quarter 2015 Results
Aug 17, 2015: Agilent Technologies Reports Third-Quarter 2015 Results
May 18, 2015: Agilent Technologies Reports Second-Quarter 2015 Results
Feb 17, 2015: Agilent Technologies Reports First-Quarter 2015 Results
Corporate Communications
Jan 06, 2016: Agilent Technologies Names Michael Tang Senior Vice President, General Counsel and Secretary
Nov 02, 2015: A. Barry Rand Retires from Agilent Technologies Board of Directors
Sep 15, 2015: Sue H. Rataj, Former Energy Executive, to Join Agilent Technologies Board of Directors
Mar 18, 2015: Agilent Technologies Announces New CEO Mike McMullen
Mar 18, 2015: Daniel K. Podolsky, M.D., of University of Texas Southwestern Medical Center, to Join Agilent Technologies Board of Directors
Legal and Regulatory
Jan 06, 2016: ENZO Biochem Reaches $9 Million Patent Infringement Settlement with Agilent Technologies
Apr 22, 2015: Agilent Technologies Announces Resolution to U.S. FDA Warning Letter for Dako Denmark
Product News
Feb 26, 2015: Agilent Technologies Introduces ClearSeq to Advance Clinical Cancer Research
Jan 27, 2015: Agilent Gets Chinese Approval For SureScan Dx Microarray Scanner
Product Approvals
Jan 27, 2015: Agilent Gets Chinese Approval For SureScan Dx Microarray Scanner
Other Significant Developments
Jul 28, 2016: Agilent Technologies Array CGH Platform Assures Quality of Cancer Cell Lines Used in Biomedical Research
Mar 14, 2016: Agilent Publishes Overview of Best Practices for Breast Cancer Diagnosis
Feb 11, 2016: Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics
Feb 11, 2016: TRADE NEWS: Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics
Jan 27, 2016: Agilent Technologies Wins Award for Innovation in Liquid Chromatography
Jan 19, 2016: Agilent Technologies Extends Agreement with PerkinElmer on Bioanalyzer Chips
May 28, 2015: Agilent Technologies to Focus on 'Powerful Partnerships, Inspiring Results' at ASMS 2015
Mar 17, 2015: Agilent Technologies Receives Innovation Award for Multiple Heart-Cutting Solution
Mar 09, 2015: Agilent Technologies Announces Major University Client for Informatics Software
Jan 16, 2015: Agilent Technologies Names Alacris Theranostics as Certified Provider of Target Enrichment Services
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer 137

LIST OF TABLES

Agilent Technologies, Inc., Medical Equipment, Key Facts, 2015
Agilent Technologies, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Agilent Technologies, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Agilent Technologies, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Agilent Technologies, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Agilent Technologies, Inc., Deals By Market, 2010 to YTD 2016
Agilent Technologies, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Dako To Acquire Intellectual Property Rights From System Dynamics
Seahorse Bioscience Raises US$11 Million In Series E Financing
Seahorse Bioscience Secures US$5 Million In Series D Financing
Linden Acquires Hycor Biomedical From Agilent Technologies
Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection
Seahorse Bioscience Enters Into Licensing Agreement With Pioneer Valley Life Sciences
Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool
Agilent Technologies Enters Into Licensing Agreement With Kreatech Diagnostics
Agilent Technologies Enters into Agreement with Burning Rock Biotech
Agilent Technologies Enters into Co-Marketing Agreement with Applied Spectral Imaging
Agilent Technologies Enters into Agreement with Eurofins Genomics
Agilent Technologies Enters into Agreement with 10X Genomics
Agilent Technologies Enters into Agreement with Thermo Fisher Scientific
Merck and Pfizer Enters into Agreement with Dako
Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic
Dako Enters into Development Agreement with ONO PHARMA for Opdivo
Agilent Extends Co-Marketing Agreement with MRM Proteomics
Dako Enters into Agreement with Merck for Companion Diagnostic Test
Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine
Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test
Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay
Agilent Enters Into Research Agreement With Chungnam National University
Agilent Technologies Enters Into Co-Development Agreement With Florida International University
Agilent Technologies Enters Into Co-Development Agreement With Sera Prognostics
Dako Enters Into Agreement With Pfizer For Companion Diagnostics
Agilent Technologies Enters Into Research Agreement With Ameritox
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests
Advion Enters Into Technology Integration Agreement With Agilent Technologies
Agilent Technologies Enters Into Co-Marketing Agreement With Molecular Discovery
Agilent Technologies Enters Into Co-Marketing Agreement With MRM Proteomics
Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers
Dako Enters Into Co-Development Agreement With Amgen
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics
Dako Enters Into Co-Development Agreement With Amgen
Dako Enters Into Co-Development Agreement With Bristol-Myers
Agilent Technologies Enters Into Co-Marketing Agreement With Bridge12 Technologies
Dako Denmark Enters Into Co-Development Agreement With Epitomics
Nikon Instruments Enters Into Distribution Agreement With Agilent Technologies
Dako Enters Into Distribution Agreement With BioPorto
Agilent Technologies Enters Into Collaboration With Wyss Institute for Biologically Inspired Engineering at Harvard University
Dako Enters Into Agreement With Quintiles Transnational
Royal Philips Electronics Signs An Agreement With Dako
Dako Enters Into An Agreement With Omnyx
Agilent Technologies Enters Into Co-Marketing Agreement With Integrated DNA Technologies
BIOCIUS Life Sciences Enters Into Distribution Agreement With Wako Pure Chemical Industries
AstraZeneca Enters Into Co-Development Agreement With Dako Denmark
Agilent Technologies Enters Into Co-Marketing Agreement Covaris
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology
Eppendorf Enters Into Licensing Agreement With Agilent Technologies
Agilent Technologies Raises USD300 Million in Public Offering of Notes Due 2026
Agilent Technologies Completes Public Offering Of Notes Due 2023 For US$600 Million
Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million
Agilent Technologies Completes Public Offering Of 2.5% Senior Notes For US$250 Million
Agilent Technologies Completes Public Offering Of 5% Senior Notes For US$500 Million
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies
Persistent Systems Completes Acquisition Of Software Business From Agilent Technologies
Bruker Completes Acquisition Of Three Varian Product Lines From Agilent Technologies
Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million
Agilent Technologies Acquires Seahorse Bioscience for USD235 Million
Agilent to Acquire Cartagenia
Agilent Technologies To Acquire ABC Instrumentacion Analitica
Leica Biosystems Completes Acquisition Of Aperio Technologies
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion
Agilent Technologies Completes Acquisition Of BioSystem Development
Agilent Technologies Acquires P.V.R.
Agilent Technologies Acquires Lab901
Agilent Technologies Completes Acquisition Of Varian
Agilent Technologies, Inc., Key Competitors
Agilent Technologies, Inc., Key Employees
Agilent Technologies, Inc., Subsidiaries 103

LIST OF FIGURES

Agilent Technologies, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Agilent Technologies, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Agilent Technologies, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Agilent Technologies, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Agilent Technologies, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Agilent Technologies, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Agilent Technologies, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Agilent Technologies, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Agilent Technologies, Inc. (A) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: